KOD
Kodiak Sciences Inc. · Healthcare · Biotechnology
Momentum inputs (comparable managers):
holder breadth +11.1% ·
share flow -3.9% ·
net new positions +10.0%
· formula
Ownership fragmentation: more holders, smaller aggregate stake
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q1 2025
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 78 | +7 | 23.28M | $907.00M | +13 | −5 |
| Q1 2026 | 73 | +1 | 22.77M | $867.18M | +7 | −7 |
| Q4 2025 | 73 | 0 | 22.52M | $629.54M | +1 | n/a |
| Q3 2025 | 18 | +2 | 13.89M | $227.40M | +2 | n/a |
| Q2 2025 | 13 | 0 | 11.40M | $42.51M | +1 | −1 |
| Q1 2025 | 10 | +1 | 5.74M | $16.11M | +1 | n/a |
| Q4 2024 | 9 | -1 | 5.98M | $59.47M | +2 | −3 |
| Q3 2024 | 9 | +3 | 2.45M | $6.41M | +3 | n/a |
| Q2 2024 | 6 | n/a | 2.71M | $6.38M | n/a | n/a |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Adage Capital Partners ✦ | 1.33M | +16.3% | $3.72M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 2 | Point72 Asset Management ✦ | 1.07M | +104.8% | $3.01M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 3 | State Street Global Advisors ✦ (passive) | 849.25K | +2.2% | $2.38M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 4 | Geode Capital Management ✦ (passive) | 793.59K | +3.2% | $2.23M | 0.0% | ▲ Add | 4 | SEC ↗ ×2 |
| 5 | D. E. Shaw & Co. ✦ | 768.42K | -9.8% | $2.16M | 0.0% | ▼ Trim | 4 | SEC ↗ ×2 |
| 6 | Renaissance Technologies ✦ | 702.60K | +52.2% | $1.97M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 7 | Two Sigma Investments ✦ | 106.66K | +115.9% | $299,193 | 0.0% | ▲ Add | 4 | SEC ↗ |
| 8 | AQR Capital Management ✦ | 66.99K | New | $187,918 | 0.0% | New | 1 | SEC ↗ ×5 |
| 9 | T. Rowe Price ✦ | 35.77K | -97.2% | $101,000 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 10 | Millennium Management ✦ | 21.75K | -73.5% | $61,014 | 0.0% | ▼ Trim | 4 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| AQR Capital Management | $187,918 | 0.0% |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 186 holders, 57.91M shares, $2.09B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
Director, 10% owner · 1.42K sh @ 85.89 · $121,614
Director, 10% owner · 84 sh @ 85.89 · $7,214
Director, 10% owner · 20.03K sh @ 85.40 · $1.71M
Director, 10% owner · 10.38K sh @ 84.24 · $874,517
Director, 10% owner · 619 sh @ 84.24 · $52,146
Director, 10% owner · 1.20K sh @ 85.40 · $102,057
Director, 10% owner · 2.58K sh @ 68.37 · $176,746
Director, 10% owner · 154 sh @ 68.37 · $10,530
Director, 10% owner · 44.69K sh @ 61.63 · $2.75M
Director, 10% owner · 5.38K sh @ 67.10 · $361,114
Open-market sales (S)
Officer · 100 sh · $9,491
Officer · 2.98K sh · $273,904
Officer · 2.00K sh · $185,320
Officer · 8.51K sh · $746,422
Officer · 5.10K sh · $464,089
Officer · 7.62K sh · $684,088
Officer · 2.00K sh · $187,420
Officer · 1.68K sh · $149,588
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology
35.0% of class · View original SEC filing ↗